Martindale: the extra pharmocopoeia, 31st edn.London: Pharmaceutical Press, 1996.
2.
Richter JE, Bradley LA, Castell DO. Esophageal chest pain current controversies in pathogenesis, diagnosis and therapy. Ann Intern Med1989; 110: 66–78.
3.
Gelfold M, Rozen P, Gilat T. Isosorbide dinitrate and nifedifine treatment of achalasia; a clinical, manumetric, and radionuclide evaluation. Gastroenterology1982; 83: 963–969.
4.
Twycross RG. Dysphagia. In: Doyle D, Hanks GWG, MacDonald N eds. Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1997.
5.
Sharma S, Walsh D. Symptom management in esophageal cancer. Chest Surg Clin North Am1984; 4: 371–377.
6.
Goyal R. Dysphagia. In: Wilson JD ed. Harrison's principles and practice of internal medicine. New York: McGraw-Hill, 1991.
7.
Konturek JW, Thor P, Lukaszyk A, Gabryelewicz A, Konturek SJ, Domschke W. Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol1997; 48: 201–209.
8.
Konturek JW, Gillessan A, Domschke W. Diffuse esophageal spasm; a malfunction that involves nitric oxide. Scand J Gastroenterol1985; 11: 1041–1050.
9.
Sykes NP, Barnes M, Carter RL. Clinical and pathological study of disease. Lancet1988; ii: 726–728.